Biotron pioneer dies
Tuesday, 16 August, 2005
Peter Gage, an internationally recognised pioneer of the use of ion channels as a treatment for viral diseases, died on August 13 after a long illness.
A professor of physiology at Australian National University's John Curtin School of Medical Research, Gage's research formed the basis of Canberra biotech company Biotron's (ASX:BIT) Virion project, an antiviral treatment nearing commercialisation for the treatment of a range of viruses including HIV and hepatitis C.
Fast-aging placentas may contribute to pre-eclampsia
Placentas affected by pre-eclampsia show several signs of accelerated aging, including increased...
BioNTech opens mRNA manufacturing facility at La Trobe
Offering state-subsidised access to researchers and biotech startups, the facility aims to enable...
Personalised melanoma vaccine cuts risk of recurrence
Adding a personalised, mRNA-based cancer vaccine to standard immunotherapy after surgery for...
